- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT06029751
Dynamic Follow-up of Factors Influencing Implant Success and Models for Predicting Implant Outcomes
November 16, 2024 updated by: Yi Zhou, The Dental Hospital of Zhejiang University School of Medicine
Nowadays, artificial intelligence technology with machine learning as the main means has been increasingly applied to the oral field, and has played an increasingly important role in the examination, diagnosis, treatment and prognosis assessment of oral diseases.
Among them, machine learning is an important branch of artificial intelligence, which refers to the system learning specific statistical patterns in a given data set to predict the behavior of new data samples [8].
Machine learning is divided into two main categories: Supervised learning and Unsupervised learning.
Whether there is supervision depends on whether the data entered is labeled or not.
If the input data is labeled, it is supervised learning.
Unlabeled learning is unsupervised.
Supervised learning is a kind of learning algorithm when the correct output of the data set is known.
Because the input and output are known, it means that there is a relationship between the input and output, and the supervised learning algorithm is to discover and summarize this "relationship".
Unsupervised learning refers to a class of learning algorithms for unlabeled data.
The absence of label information means that patterns or structures need to be discovered and summarized from the data set.
Study Overview
Detailed Description
Starting from different data types, researchers built a variety of models to mine the data itself and predict the prognosis of the implant.
Machine learning is often more impressive and intuitive in terms of images.
In the field of oral implantology, researchers analyze preoperative image data based on machine learning to identify important anatomical structures (such as maxillary sinus, mandibular neural tube, etc.) and analyze alveolar bone quality.
Large-scale imaging data is also used to identify the different implant systems on the market.
Machine learning also plays an important role in the development of implant surgery plans, which is conducive to more accurate and efficient implantation surgery.
The evaluation of implant retention rate and individual bone level is also one of the key clinical concerns.
Most methods to study such issues are: Kaplan-Meier survival analysis, Cox survival analysis, etc., to study implant retention rate and influencing factors.
Linear (mixed) model and multiple logistic regression were used to study the changes and influencing factors of bone absorption at implant edge.
However, in daily clinical practice, there may be some practical problems such as lost follow-up and partial data missing.
As the clinical scenarios of research become more and more clear, even partial data missing often leads to results that cannot be accurately evaluated and predicted.
Therefore, in terms of supervised learning, this study aims to establish a predictive model of implant bone level change and evaluate the accuracy of the model through machine learning of implant edge bone level (MBL) with large amounts of data.
In terms of unsupervised learning, the aim is to identify susceptibility phenotypes to implant failure through: clustering of individual-related information about implants.
Study Type
Observational
Enrollment (Estimated)
1000
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Contact
- Name: Yi Zhou
- Phone Number: 0571 87217419
- Email: zhouyizyzyzy@163.com
Study Contact Backup
- Name: Siyao Ma
- Phone Number: 0571 87217419
- Email: 1123348672@qq.com
Study Locations
-
-
Zhejiang
-
Hangzhou, Zhejiang, China, 310003
- Recruiting
- The Stomatologic Hospital, School of Medicine, Zhejiang University
-
Contact:
- Yi Zhou
- Phone Number: 0571 87217419
-
Contact:
- Siyao Ma
- Phone Number: 0571 87217419
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
- Adult
- Older Adult
Accepts Healthy Volunteers
Yes
Sampling Method
Probability Sample
Study Population
This was a retrospective study.
After searching the literature identified by the sample size of the combined model prediction method, it was determined that the initial data and follow-up data of 1000 patients were required.
Description
Inclusion Criteria:
- Patients aged 18 years and above;
- 1-5 years after implantation;
- Implantation torque > 35N·cm;
- Signed informed consent.
Exclusion Criteria:
- Contraindications of general implantation surgery;
- Have received head and neck radiation therapy;
- Past or current treatment with bisphosphonates;
- Do not cooperate with the interviewer.
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Mean Bone Level of dental implant
Time Frame: 1-7 years
|
The vertical distance between the implant and the first contact area of bone and the tip of the implant (mesial and distal)
|
1-7 years
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Investigators
- Principal Investigator: Weida Li, Stomatological Hospital Affiliated to Zhejiang University School of Medicine
Publications and helpful links
The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.
General Publications
- Papantonopoulos G, Gogos C, Housos E, Bountis T, Loos BG. Prediction of individual implant bone levels and the existence of implant "phenotypes". Clin Oral Implants Res. 2017 Jul;28(7):823-832. doi: 10.1111/clr.12887. Epub 2016 Jun 1.
- Raynaud M, Aubert O, Divard G, Reese PP, Kamar N, Yoo D, Chin CS, Bailly E, Buchler M, Ladriere M, Le Quintrec M, Delahousse M, Juric I, Basic-Jukic N, Crespo M, Silva HT Jr, Linhares K, Ribeiro de Castro MC, Soler Pujol G, Empana JP, Ulloa C, Akalin E, Bohmig G, Huang E, Stegall MD, Bentall AJ, Montgomery RA, Jordan SC, Oberbauer R, Segev DL, Friedewald JJ, Jouven X, Legendre C, Lefaucheur C, Loupy A. Dynamic prediction of renal survival among deeply phenotyped kidney transplant recipients using artificial intelligence: an observational, international, multicohort study. Lancet Digit Health. 2021 Dec;3(12):e795-e805. doi: 10.1016/S2589-7500(21)00209-0. Epub 2021 Oct 28.
- Cetiner D, Isler SC, Bakirarar B, Uraz A. Identification of a Predictive Decision Model Using Different Data Mining Algorithms for Diagnosing Peri-implant Health and Disease: A Cross-Sectional Study. Int J Oral Maxillofac Implants. 2021 Sep-Oct;36(5):952-965. doi: 10.11607/jomi.8965.
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
January 1, 2017
Primary Completion (Estimated)
December 31, 2025
Study Completion (Estimated)
December 31, 2025
Study Registration Dates
First Submitted
September 1, 2023
First Submitted That Met QC Criteria
September 1, 2023
First Posted (Actual)
September 8, 2023
Study Record Updates
Last Update Posted (Estimated)
November 19, 2024
Last Update Submitted That Met QC Criteria
November 16, 2024
Last Verified
September 1, 2023
More Information
Terms related to this study
Other Study ID Numbers
- DHZhejiangU-2022(005)
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
NO
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Implant Site Reaction
-
National Research Centre, EgyptCompletedImplant Complication | Implant Site ReactionEgypt
-
Cairo UniversityNot yet recruitingDental Implant Failed | Implant Site Reaction
-
Universidad Complutense de MadridRecruiting
-
University of CagliariRecruiting
-
Mahidol UniversityRecruiting
-
Mohamed Reda Mohamed AbdelhadyCompletedImplant Site ReactionEgypt
-
October University for Modern Sciences and ArtsCompletedImplant Site ReactionEgypt
-
Cairo UniversityCompleted
-
National Research Centre, EgyptCompleted
-
Cairo UniversityUnknownImplant Site Reaction
Clinical Trials on No intervention
-
Hopital FochNot yet recruitingInterstitial Lung DiseaseFrance
-
Wave NeuroscienceCompletedAutistic DisorderUnited States
-
University of Alabama at BirminghamCompletedInflammatory Bowel Diseases | Colorectal Cancer | Diverticular Diseases | Social BehaviorUnited States
-
Janssen Research & Development, LLCCompletedLupus Erythematosus, Systemic | Lupus Erythematosus, Cutaneous | Lupus Erythematosus, DiscoidUnited States, Poland
-
Hospital Universitario La Paz3MVX CCB and Agaplesion Markus Krankenhaus, Frankfurt a.M., Germany.; Department...RecruitingEmbolism | Atrial Fibrillation | Arrhythmia | Stroke, Acute | Stroke Sequelae | AblationSpain
-
Southern California College of Optometry at Marshall...Ohio State University; University of Houston; Alcon Research; University of Waterloo and other collaboratorsCompletedContact Lens Complication | Contact Lens Acute Red Eye | Contact Lens Related Corneal Infiltrate (Disorder) | Contact Lens-Induced Corneal Fluorescein StainingUnited States, Canada
-
Huashan HospitalZhejiang Cancer Hospital; Shanghai Zhongshan Hospital; Tongji Hospital; Qilu Hospital... and other collaboratorsRecruitingHead and Neck Squamous Cell Carcinoma | Patient Derived Organoid | Drug Sensitive Test in VitroChina
-
China Medical University HospitalUnknownIntention to Stay, Turnover Behavior
-
University of Dublin, Trinity CollegeCompleted